UroGen Pharma Ltd.(URGN)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
URGN has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±10.5%).
Did the stock rise after good news?
The next-day move after each of its last 2 EPS beats and 7 misses.
- Nov '26Missed▼ -16.5%
- May '26Beat▲ +10.2%
- Mar '26Missed▼ -12.4%
- Aug '25Missed▼ -7.1%
- May '25Missed▲ +7.3%
- Nov '24Beat▲ +0.2%
- Aug '24Missed▲ +3.1%
- May '24Missed▲ +2.6%
- Mar '24Missed▼ -18.0%
Clear beats and misses with a known reaction only. What counts as a beat
Why did URGN rise after missing earnings?
3 of URGN's last 9 reactions went against the EPS result. What stands out in each:
Rose despite an EPS miss (3 of 7)
- May 12, 2025EPS missed -16.5%stock +7.3% next day
- It had already fallen 9.8% in the final week before the report, so weak results may have been expected.
- Aug 13, 2024EPS missed -9.6%stock +3.1% next day
- It had already fallen 19.0% in the 20 trading sessions before the report, so weak results may have been expected.
- May 13, 2024EPS missed -11.5%stock +2.6% next day
- It had already fallen 15.6% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was URGN's earnings move already priced in?
URGN's move in the month before each of its last 11 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 11 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does URGN hold its opening gap after earnings?
URGN's opening move after each report and where it closed that day.
In 10 reports URGN opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 10 times (50%), and fully reversed 4 times. Gaps up faded 1 of 3; gaps down recovered 4 of 7.
- Nov 4, 2026HeldOpened -4.0%, closed -16.5%
- Aug 5, 2026HeldOpened +5.6%, closed +16.3%
- May 6, 2026HeldOpened +5.8%, closed +10.2%
- Nov 6, 2025ReversedOpened -5.3%, closed +21.9%
- Aug 7, 2025HeldOpened -3.4%, closed -7.1%
- May 12, 2025ReversedOpened -4.6%, closed +7.3%
- Nov 6, 2024FadedOpened +8.5%, closed +0.2%
- Aug 13, 2024ReversedOpened -2.3%, closed +3.1%
URGN earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | Revenue surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | Before open | $0.10 | -$0.03 | -130.0% | -3.0% | -16.45% | — |
| Aug 5, 2026 | Before open | -$0.26 | -$0.28 | sources differ | — | +16.31% | +17.64% |
| May 6, 2026 | Before open | -$0.48 | -$0.47 | +2.1% | — | +10.16% | +23.37% |
| Mar 2, 2026 | Before open | -$0.51 | -$0.53 | -3.9% | — | -12.35% | -7.10% |
| Nov 6, 2025 | Before open | -$0.68 | -$0.69 | sources differ | — | +21.91% | +19.78% |
| Aug 7, 2025 | Before open | -$0.83 | -$1.05 | -26.5% | — | -7.10% | -8.85% |
| May 12, 2025 | Before open | -$0.79 | -$0.92 | -16.5% | — | +7.32% | -4.91% |
| Mar 10, 2025 | Before open | -$0.72 | -$0.80 | -11.1% | — | — | — |
| Nov 6, 2024 | Before open | -$0.82 | -$0.55 | +32.9% | — | +0.25% | -0.74% |
| Aug 13, 2024 | Before open | -$0.83 | -$0.91 | -9.6% | — | +3.10% | +6.75% |
| May 13, 2024 | Before open | -$0.87 | -$0.97 | -11.5% | — | +2.59% | +8.16% |
| Mar 14, 2024 | Before open | -$0.68 | -$0.72 | -5.9% | — | -17.97% | -17.00% |
URGN Earnings FAQ
Answers computed from UroGen Pharma Ltd.'s reported history
URGN has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
Over the last 10 quarters with a usable EPS surprise, URGN beat the consensus estimate 2 times (20%), missed 8 and landed in line 0. 2 quarters where our data sources disagree on beat versus miss are shown but not counted.
Across its last 11 quarters with a measured reaction, URGN moved an average of ±10.5% in the first session after reporting. It closed higher 64% of the time; the largest gain was 21.9% and the largest drop -18.0%.
Across its last 11 quarters with price data, URGN moved an average of +4.0% in the 20 trading sessions before reporting and was higher in 55% of them. After a run-up of 3% or more (6 quarters), it fell the next day 33% of the time, averaging +6.0%. After a drop of 3% or more (5 quarters), it rose the next day 60% of the time, averaging -5.7%. This describes past reports; it is not a forecast.
In 10 reports URGN opened at least 1% away from the previous close. It gave back half or more of that gap by the close 5 of 10 times (50%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · URGN: 12 reported quarters, latest Nov 4, 2026. Information only, not investment advice.
Looking for more on URGN?
Price charts, forecast, fundamentals and risk pages for URGN are not on Tickzen yet. You can run a full stock analysis now.
Run the URGN Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun